- Home
- ANTX vs NLOP Comparison
ANTX vs NLOP Comparison
Compare ANTX & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANTX | NLOP |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.7M | 176.7M |
| IPO Year | 2022 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ANTX | NLOP |
|---|---|---|
| Price | $5.10 | $11.31 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 239.6K | 131.8K |
| Earning Date | 05-13-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 52.20% |
| EPS Growth | ★ 32.56 | N/A |
| EPS | N/A | ★ 1.69 |
| Revenue | N/A | ★ $118,915,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.57 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $11.08 |
| 52 Week High | $6.91 | $34.53 |
Technical Indicators
Market Signals| Indicator | ANTX | NLOP |
|---|---|---|
| Relative Strength Index (RSI) | 61.53 | 36.64 |
| Support Level | $1.06 | N/A |
| Resistance Level | $6.91 | $12.26 |
| Average True Range (ATR) | 0.40 | 0.29 |
| MACD | 0.07 | -0.03 |
| Stochastic Oscillator | 84.25 | 21.62 |
Price Performance
Historical ComparisonAbout ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
About NLOP Net Lease Office Properties of Beneficial Interest
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns, operates, and finances a diversified portfolio of office properties mainly leased to corporate tenants on a single-tenant, net-lease basis. The company operates as a single operating and reportable segment focused on owning and managing office properties that generate revenue mainly from long-term lease agreements with tenants.